BXRX Annual Cash & Cash Equivalents
$5.26 M
-$10.63 M-66.91%
31 December 2022
Summary:
As of February 5, 2025, BXRX annual cash & cash equivalents is $5.26 million, with the most recent change of -$10.63 million (-66.91%) on December 31, 2022. During the last 3 years, it has fallen by -$12.48 million (-70.36%).BXRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BXRX Quarterly Cash And Cash Equivalents
$363.00 K
-$1.05 M-74.36%
01 September 2023
Summary:
As of February 5, 2025, BXRX quarterly cash and cash equivalents is $363.00 thousand, with the most recent change of -$1.05 million (-74.36%) on September 1, 2023. Over the past year, it has dropped by -$5.28 million (-93.57%).BXRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BXRX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -66.9% | -93.6% |
| 3 y3 years | -70.4% | -98.5% |
| 5 y5 years | - | - |
BXRX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -82.7% | -99.1% |
Baudax Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $363.00 K(-74.4%) |
| June 2023 | - | $1.42 M(-62.8%) |
| Mar 2023 | - | $3.80 M(-27.7%) |
| Dec 2022 | $5.26 M(-66.9%) | $5.26 M(-6.9%) |
| Sept 2022 | - | $5.65 M(+8.4%) |
| June 2022 | - | $5.21 M(-54.8%) |
| Mar 2022 | - | $11.53 M(-27.5%) |
| Dec 2021 | $15.89 M | $15.89 M(+7.6%) |
| Sept 2021 | - | $14.77 M(-41.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $25.41 M(-17.2%) |
| Mar 2021 | - | $30.69 M(+1.1%) |
| Dec 2020 | $30.34 M(+71.0%) | $30.34 M(+23.3%) |
| Sept 2020 | - | $24.61 M(-37.6%) |
| June 2020 | - | $39.41 M(+2.9%) |
| Mar 2020 | - | $38.28 M(+115.8%) |
| Dec 2019 | $17.74 M(>+9900.0%) | $17.74 M(>+9900.0%) |
| Sept 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Baudax Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Baudax Bio?
- What is Baudax Bio annual cash & cash equivalents year-on-year change?
- What is Baudax Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Baudax Bio?
- What is Baudax Bio quarterly cash and cash equivalents year-on-year change?
What is Baudax Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of BXRX is $5.26 M
What is the all time high annual cash & cash equivalents for Baudax Bio?
Baudax Bio all-time high annual cash & cash equivalents is $30.34 M
What is Baudax Bio annual cash & cash equivalents year-on-year change?
Over the past year, BXRX annual cash & cash equivalents has changed by -$10.63 M (-66.91%)
What is Baudax Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BXRX is $363.00 K
What is the all time high quarterly cash and cash equivalents for Baudax Bio?
Baudax Bio all-time high quarterly cash and cash equivalents is $39.41 M
What is Baudax Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, BXRX quarterly cash and cash equivalents has changed by -$5.28 M (-93.57%)